Lv4
480 积分 2024-08-05 加入
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
1个月前
已完结
Multi-omics analyses reveal the pathogenic role of terminal ileum-derived IgA+β7+ cells in IgA nephropathy
1个月前
已完结
Role of the gut microbiota in the pathogenesis of IgA nephropathy
2个月前
已完结
Serum uric acid, body mass index, and cardiovascular diseases: A multiple two-step Mendelian randomization study
3个月前
已完结
Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease
3个月前
已完结
Attribute-based medicine for IgA nephropathy: risk factor constellations influence kidney prognosis
3个月前
已完结
Oxidative Stress and Galactose-Deficient IgA1 as Markers of Progression in IgA Nephropathy
3个月前
已完结
IgA nephropathy
3个月前
已完结
Expert consensus for the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2025 update
3个月前
已完结
Dual Mechanisms of Hyperuricemia‐Associated Renal Injury: A Systematic Review of Crystal‐Dependent and Crystal‐Independent Pathways
3个月前
已完结
皖公网安备34019202002308
